Drug Insights

Your Ultimate Guide to Finding Ibuprofen on Synapse

1 February 2024
2 min read

Ibuprofen, a small molecule drug, functions as a COX inhibitor. Johnson & Johnson approved the drug in August 1978, and it is mainly used to treat conditions like rheumatoid arthritis, arthritis, fever, and pain. Ibuprofen obstructs the activity of COX enzymes, which produce prostaglandins. These hormones are involved in inflammation and pain signaling. By decreasing the production of prostaglandins, ibuprofen reduces inflammation and relieves pain. Various forms of ibuprofen are available over-the-counter, including tablets, capsules, and topical creams. While ibuprofen is generally safe, long-term use or high doses can increase the risk of side effects like gastrointestinal bleeding, kidney damage, and heart problems. Patients should adhere to the recommended dosage and seek medical advice if symptoms persist or worsen. Click on the image below to begin the exploration journey of Ibuprofen through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Explore Metoprolol Tartrate on Synapse: Tips and Tricks for Better Search Results
Drug Insights
2 min read
Explore Metoprolol Tartrate on Synapse: Tips and Tricks for Better Search Results
1 February 2024
Metoprolol Tartrate is a medication that blocks β-adrenoceptors, and it was approved in 1978 by AstraZeneca PLC.
Read →
Sionna Therapeutics Reveals Start of First Stage Clinical Trials with SION-109 for Treating Cystic Fibrosis
Latest Hotspot
3 min read
Sionna Therapeutics Reveals Start of First Stage Clinical Trials with SION-109 for Treating Cystic Fibrosis
1 February 2024
Sionna Therapeutics has revealed the administration of the initial dose to a healthy participant in the Stage 1 clinical study for SION-109.
Read →
Strategically Search Atorvastatin on Synapse: A How-to Guide
Drug Insights
2 min read
Strategically Search Atorvastatin on Synapse: A How-to Guide
1 February 2024
Atorvastatin is a medication that inhibits the HMG-CoA reductase enzyme. Hanmi Pharmaceutical Co., Ltd approved it in January 2008.
Read →
Sciwind Biosciences Announces Promising Initial Clinical Results for Oral, Sustained-Release GLP-1 Mimetic Ecnoglutide, XW004
Latest Hotspot
4 min read
Sciwind Biosciences Announces Promising Initial Clinical Results for Oral, Sustained-Release GLP-1 Mimetic Ecnoglutide, XW004
1 February 2024
Sciwind Biosciences Reports Encouraging Outcomes from Initial Clinical Study of XW004, Its Oral Version of Sustained-Release GLP-1 Mimetic Ecnoglutide.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.